Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 201: What is the commonest side effect of Dapsone?

A. Hemolytic anemia (Correct Answer)
B. Thrombocytopenia
C. Cyanosis
D. Bone marrow depression

Explanation: ### Explanation **Correct Option: A. Hemolytic anemia** Dapsone (Diaminodiphenyl sulfone) is a sulfone used primarily in the treatment of Leprosy and Dermatitis Herpetiformis. The **most common side effect** of Dapsone is **dose-related hemolysis** (hemolytic anemia). * **Mechanism:** Dapsone is a strong oxidizing agent. It causes oxidative stress on red blood cells (RBCs), leading to the denaturation of hemoglobin. This results in the formation of **Heinz bodies**, which are then removed by splenic macrophages (forming "bite cells"), leading to hemolysis. * **Risk Factor:** While it can occur in anyone at high doses, patients with **G6PD deficiency** are at a significantly higher risk because they lack the protective antioxidant mechanism (NADPH) to neutralize oxidative stress. **Analysis of Incorrect Options:** * **B. Thrombocytopenia:** While Dapsone can rarely cause blood dyscrasias, it is not a common or characteristic side effect compared to its effects on RBCs. * **C. Cyanosis:** This is a known side effect caused by **Methemoglobinemia** (another oxidative effect of Dapsone). While frequent, it is clinically less common and usually less severe than the drop in hemoglobin levels seen in hemolysis. * **D. Bone marrow depression:** This is a rare, idiosyncratic reaction (e.g., agranulocytosis) rather than the common dose-dependent hemolysis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dapsone Syndrome:** A severe hypersensitivity reaction occurring 4–6 weeks after starting therapy, characterized by fever, malaise, exfoliative dermatitis, and hepatitis. 2. **Drug of Choice:** Dapsone is the DOC for **Dermatitis Herpetiformis**. 3. **Screening:** It is mandatory to screen for **G6PD levels** before initiating Dapsone therapy to prevent severe hemolytic crises. 4. **Methemoglobinemia:** If a patient on Dapsone presents with "chocolate-colored blood" or cyanosis unresponsive to oxygen, the treatment is **Methylene Blue**.

Question 202: Which of the following is an anti-IgE monoclonal antibody?

A. Certolizumab
B. Ofatumumab
C. Omalizumab (Correct Answer)
D. Canakinumab

Explanation: **Explanation:** **Correct Answer: C. Omalizumab** Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to **free human immunoglobulin E (IgE)** in the blood and interstitial fluid. By binding to the Fc portion of the IgE molecule, it prevents IgE from attaching to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. This inhibits the release of inflammatory mediators (like histamine and leukotrienes) that cause allergic responses. It is clinically used for moderate-to-severe persistent **allergic asthma** and chronic spontaneous urticaria. **Analysis of Incorrect Options:** * **A. Certolizumab:** This is a pegylated Fab' fragment of a humanized **TNF-α inhibitor**. It is used in the treatment of Crohn’s disease and rheumatoid arthritis. * **B. Ofatumumab:** This is a human monoclonal antibody that targets **CD20** on B-lymphocytes (similar to Rituximab). It is used in chronic lymphocytic leukemia (CLL) and multiple sclerosis. * **C. Canakinumab:** This is a human monoclonal antibody against **Interleukin-1 beta (IL-1β)**. It is used in systemic juvenile idiopathic arthritis and cryopyrin-associated periodic syndromes (CAPS). **High-Yield NEET-PG Pearls:** * **Route of Administration:** Omalizumab is administered **subcutaneously**. * **Key Indication:** It is specifically indicated for patients with asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. * **Mnemonic for Monoclonal Antibodies:** * "-umab": Human * "-ximab": Chimeric * "-zumab": Humanized * "-omab": Mouse

Question 203: Which of the following drugs cannot be removed by dialysis?

A. Propranolol
B. Digoxin
C. Morphine
D. Furosemide (Correct Answer)

Explanation: **Explanation:** The dialyzability of a drug depends on its physicochemical properties. Drugs that **cannot** be effectively removed by hemodialysis typically possess at least one of the following characteristics: **High protein binding**, **Large volume of distribution (Vd)**, or **High molecular weight**. **Why Furosemide is the Correct Answer:** Furosemide is highly protein-bound (approximately **91–99%**, primarily to albumin). Since only the "free" (unbound) fraction of a drug can pass through the semi-permeable membrane of the dialysis machine, drugs with such high protein binding remain in the intravascular compartment and are not cleared by dialysis. **Analysis of Incorrect Options:** * **Propranolol:** While it has high protein binding and a large Vd, it is generally considered "not dialyzable" in many texts. However, in the context of this specific MCQ (often sourced from standard exams like AIIMS/PGI), Furosemide is the most definitive answer due to its near-total protein binding. * **Digoxin:** It cannot be removed by dialysis, but for a different reason: it has an **extremely large Volume of Distribution (Vd > 500L)**. It sequestered in the tissues (heart and skeletal muscle), leaving very little drug in the plasma to be filtered. * **Morphine:** Similar to Digoxin, Morphine has a large Vd and is not effectively removed by dialysis. *Note: In many clinical scenarios, all four drugs listed are actually considered "not dialyzable." However, for NEET-PG, Furosemide is frequently tested as the classic example of a drug limited by **protein binding**.* **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Dialyzable Drugs (BLAST-M):** **B**arbiturates (Phenobarbital), **L**ithium, **A**lcohol (Ethanol/Methanol), **S**alicylates, **T**heophylline, **M**etformin. * **Vd Rule:** If Vd is **> 1 L/kg**, the drug is generally not dialyzable. * **Protein Binding Rule:** If protein binding is **> 90%**, the drug is generally not dialyzable.

Question 204: A 41-year-old woman with glaucoma is treated with acetazolamide. Several weeks later, she has an arterial pH of 7.34, an arterial PCO2 of 29 mm Hg, and a plasma HCO3- of 15 mEq/L. Which of the following abnormalities has this woman most likely developed?

A. Metabolic acidosis (Correct Answer)
B. Metabolic alkalosis
C. Mixed acidosis
D. Mixed alkalosis

Explanation: ### **Explanation** **1. Why Metabolic Acidosis is Correct:** Acetazolamide is a **carbonic anhydrase inhibitor** that acts on the proximal convoluted tubule of the kidney. It inhibits the reabsorption of sodium bicarbonate ($NaHCO_3$), leading to "bicarbonate wasting" in the urine. * **Mechanism:** By preventing the conversion of $H_2CO_3$ to $H_2O$ and $CO_2$ in the lumen, it causes a significant loss of $HCO_3^-$ in the urine. * **Laboratory Findings:** The patient’s $HCO_3^-$ is low (15 mEq/L; Normal: 22–28), and the pH is acidic (7.34; Normal: 7.35–7.45). This confirms a **primary metabolic acidosis**. * **Compensation:** The low $PCO_2$ (29 mm Hg; Normal: 35–45) indicates that the lungs are compensating by "blowing off" $CO_2$ (respiratory compensation), but the primary insult remains metabolic. **2. Why Other Options are Wrong:** * **Metabolic Alkalosis:** This would present with an elevated pH (>7.45) and elevated $HCO_3^-$. Acetazolamide causes the opposite by depleting bicarbonate. * **Mixed Acidosis:** This would require both a low $HCO_3^-$ (metabolic) and a high $PCO_2$ (respiratory). Here, the $PCO_2$ is low, indicating appropriate compensation, not a primary respiratory disorder. * **Mixed Alkalosis:** This would involve an elevated pH with both high $HCO_3^-$ and low $PCO_2$. **3. NEET-PG High-Yield Pearls:** * **Type of Acidosis:** Acetazolamide causes a **Normal Anion Gap Metabolic Acidosis (NAGMA)**, specifically a Type 2 Renal Tubular Acidosis (RTA). * **Clinical Uses:** Glaucoma (decreases aqueous humor production), Altitude Sickness (induces metabolic acidosis to drive ventilation), and Idiopathic Intracranial Hypertension. * **Side Effects:** Hypokalemia, paresthesias, and sulfa-drug allergy cross-reactivity. * **Mnemonic for NAGMA:** **HARDUPS** (Hyperalimentation, Acetazolamide, Renal tubular acidosis, Diarrhea, Ureteroenteric fistula, Pancreatic fistula, Spironolactone).

Question 205: Which of the following drugs exhibits a narrow therapeutic window?

A. Captopril
B. Furosemide
C. Diazepam
D. Imipramine (Correct Answer)

Explanation: **Explanation** **Correct Answer: D. Imipramine** The **therapeutic window** (or index) is the range of drug dosages which can treat disease effectively without having toxic effects. Drugs with a **narrow therapeutic window** require precise dosing and often therapeutic drug monitoring (TDM) because the dose required for efficacy is very close to the dose that causes toxicity. **Imipramine**, a Tricyclic Antidepressant (TCA), is notorious for its narrow therapeutic index. In overdose, it leads to the "3 Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to sodium channel blockade). Because of this narrow safety margin, TCAs have largely been replaced by SSRIs in clinical practice. **Analysis of Incorrect Options:** * **A. Captopril:** An ACE inhibitor used for hypertension. It has a wide therapeutic window; while it can cause hypotension or hyperkalemia, these are usually predictable and manageable over a broad dose range. * **B. Furosemide:** A loop diuretic. Although potent, it has a wide safety margin. Toxicity (ototoxicity or severe dehydration) typically occurs only at extremely high intravenous doses. * **C. Diazepam:** A Benzodiazepine. These drugs are characterized by a high therapeutic index, making them much safer in overdose compared to older sedatives like Barbiturates. **NEET-PG High-Yield Pearls:** * **Mnemonic for Narrow Therapeutic Index Drugs:** "**W**ith **L**ow **T**herapeutic **I**ndex, **D**ogs **G**et **P**oisoned" (**W**arfarin, **L**ithium, **T**heophylline, **I**mipramine/TCAs, **D**igoxin, **G**entamicin/Aminoglycosides, **P**henytoin). * **TDM Requirement:** Most narrow therapeutic index drugs require TDM to ensure plasma concentrations remain within the safe "window." * **Antidote for TCA Toxicity:** Sodium Bicarbonate (used specifically to treat QRS widening and arrhythmias).

Question 206: Alkalinity of urine is done in which of the following conditions?

A. Barbiturate poisoning (Correct Answer)
B. Lithium toxicity
C. Alprazolam overdose
D. Diazepam toxicity

Explanation: **Explanation:** The correct answer is **Barbiturate poisoning**. This is based on the principle of **ion trapping**, where the ionization of a drug is manipulated to prevent its reabsorption in the renal tubules. 1. **Why Barbiturates?** Phenobarbital (a long-acting barbiturate) is a **weakly acidic drug**. According to the Henderson-Hasselbalch principle, acidic drugs become ionized (charged) in an alkaline medium. By administering Sodium Bicarbonate ($NaHCO_3$) to alkalinize the urine (pH 7.5–8.5), the barbiturate molecules become ionized. Since ionized drugs are lipid-insoluble, they cannot cross the tubular membrane back into the blood and are "trapped" in the urine, significantly increasing their renal clearance. 2. **Why the other options are incorrect:** * **Lithium:** Lithium is an alkali metal ion, not a weak acid or base. Its excretion depends on sodium levels and glomerular filtration; alkalinization does not affect its ionization or clearance. Hemodialysis is the treatment of choice for severe toxicity. * **Alprazolam & Diazepam:** These are Benzodiazepines (BZDs). While they are technically weak bases, they have a very high volume of distribution ($V_d$) and are highly protein-bound. Forced diuresis or pH manipulation is ineffective for drugs with high $V_d$. The specific antidote for BZD overdose is Flumazenil. **High-Yield Clinical Pearls for NEET-PG:** * **Urinary Alkalinization** is indicated for: **Salicylates (Aspirin)**, **Phenobarbital**, **Methotrexate**, and **Chlorpropamide**. * **Urinary Acidification** (using Ammonium Chloride) was historically used for weak bases like Amphetamines or Quinine, but it is **no longer recommended** clinically due to the risk of inducing severe systemic acidosis and rhabdomyolysis. * **Mnemonic:** "Acidic drugs need Alkaline urine" for excretion.

Question 207: Use of valproate during pregnancy may result in which of the following?

A. Mental retardation
B. Respiratory depression
C. Hydantoin syndrome
D. Neural tube defect (Correct Answer)

Explanation: **Explanation:** **Valproate** is a broad-spectrum antiepileptic drug that is highly teratogenic. It is associated with a 10-fold increase in the risk of **Neural Tube Defects (NTDs)**, specifically **spina bifida**, occurring in approximately 1-2% of exposed pregnancies. 1. **Why the correct answer is right:** Valproate interferes with folate metabolism and inhibits histone deacetylase, leading to altered gene expression during neurulation. The critical period for this toxicity is the first 28 days after conception, often before a woman knows she is pregnant. 2. **Why the incorrect options are wrong:** * **Mental retardation:** While fetal valproate syndrome can involve developmental delays, it is not the classic, specific association compared to NTDs. * **Respiratory depression:** This is an acute neonatal complication of maternal opioid or sedative use, not a structural teratogenic effect of valproate. * **Hydantoin syndrome:** This is specifically associated with **Phenytoin** exposure and is characterized by craniofacial dysmorphism, hypoplastic digits, and nail hypoplasia. **NEET-PG High-Yield Pearls:** * **Fetal Valproate Syndrome:** Includes NTDs, cleft lip/palate, and cardiovascular defects. * **Management:** If a woman on valproate plans pregnancy, switch to a safer alternative (like Levetiracetam) or use the lowest effective dose with **high-dose Folic Acid (5 mg/day)** supplementation. * **Drug of Choice:** For most seizures in pregnancy, Levetiracetam or Lamotrigine are preferred due to lower teratogenic potential. * **Other Teratogens:** * Lithium: Ebstein’s anomaly. * Warfarin: Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * ACE Inhibitors: Renal dysgenesis and skull ossification defects.

Question 208: All of the following are true about levamisole except:

A. Acts as an immunostimulator.
B. Acts as an immunodepressor in high doses.
C. A single dose is sufficient for the treatment of psoriasis. (Correct Answer)
D. Acts as an antihelminthic by causing depolarization.

Explanation: **Explanation:** Levamisole is a synthetic imidazothiazole derivative primarily used as an anthelmintic and an immunomodulator. **Why Option C is the correct answer (False statement):** Levamisole is **not** a first-line treatment for psoriasis, and a single dose is never sufficient. While it has been explored in various autoimmune conditions due to its immunomodulatory effects, its use in psoriasis is rare, experimental, and requires prolonged, intermittent dosing (e.g., 150 mg daily for 2-3 days every week). It is more commonly associated with the treatment of nephrotic syndrome in children and formerly as an adjuvant in colorectal cancer. **Analysis of Incorrect Options (True statements):** * **Option A & B:** Levamisole acts as an **immunomodulator**. At low or standard doses, it restores T-cell and macrophage function (immunostimulator). However, at high doses or prolonged use, it can lead to immunosuppression and serious adverse effects like agranulocytosis. * **Option D:** As an anthelmintic, it acts as a **nicotinic acetylcholine receptor agonist**. It causes persistent depolarization and spastic paralysis in susceptible worms (like *Ascaris lumbricoides*), leading to their expulsion. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice:** Levamisole was historically a drug of choice for Ascariasis (single dose), though Albendazole is now preferred. 2. **Adverse Effect:** The most dreaded side effect is **agranulocytosis**. 3. **Clinical Trivia:** It is often used as an adulterant in "street cocaine," which can lead to **retiform purpura** and skin necrosis. 4. **Mechanism:** It "restores" rather than "stimulates" the immune system (restores depressed T-cell function).

Question 209: Which drug commonly causes hypokalemia?

A. Amphotericin B (Correct Answer)
B. Insulin
C. Cyclosporine
D. Carbenoxolone

Explanation: **Explanation:** **Amphotericin B (Correct Answer):** Amphotericin B is a potent antifungal that causes hypokalemia primarily through **renal tubular damage**. It increases the permeability of the distal tubular membrane by creating pores, leading to a "leak" of potassium ions into the urine. Additionally, it can cause Type 1 Renal Tubular Acidosis (RTA), further exacerbating potassium loss. **Analysis of Incorrect Options:** * **Insulin:** While insulin does cause a shift of potassium from the extracellular fluid into the cells (used acutely to treat hyperkalemia), it does not "commonly cause" clinical hypokalemia as a side effect in standard therapeutic settings, provided glucose is managed. * **Cyclosporine:** This immunosuppressant is notorious for causing **hyperkalemia** (not hypokalemia) by suppressing aldosterone activity and reducing potassium excretion in the collecting ducts. * **Carbenoxolone:** This drug (used for peptic ulcers) has mineralocorticoid-like activity, which can lead to sodium retention and potassium loss. However, it is rarely used in modern clinical practice compared to Amphotericin B, which is the classic high-yield association for drug-induced hypokalemia in exams. **High-Yield Clinical Pearls for NEET-PG:** 1. **Amphotericin B Toxicity:** Often presents as a triad of Nephrotoxicity, Hypokalemia, and Hypomagnesemia. 2. **Prevention:** Pre-loading with Normal Saline (saline loading) helps reduce the risk of Amphotericin-induced nephrotoxicity. 3. **Other Hypokalemia-inducing drugs:** Loop diuretics (Furosemide), Thiazides, Beta-2 agonists (Salbutamol), and Corticosteroids. 4. **Hyperkalemia-inducing drugs:** ACE inhibitors, ARBs, Spironolactone, and NSAIDs.

Question 210: Which receptor is primarily involved in chemotherapy-induced vomiting?

A. Histamine H1 receptor
B. Serotonin 5-HT3 receptor (Correct Answer)
C. Dopamine D2 receptor
D. Opioid m receptor

Explanation: ### Explanation **Correct Option: B. Serotonin 5-HT3 receptor** Chemotherapy-induced nausea and vomiting (CINV) is primarily mediated by the release of **serotonin** from enterochromaffin cells in the gastrointestinal tract. This serotonin activates **5-HT3 receptors** on vagal afferent nerves, which transmit signals to the **Chemoreceptor Trigger Zone (CTZ)** and the Solitary Tract Nucleus (STN) in the medulla. 5-HT3 antagonists (e.g., Ondansetron) are the first-line agents for preventing acute CINV because they block these peripheral and central receptors. **Incorrect Options:** * **A. Histamine H1 receptor:** These receptors are primarily involved in **motion sickness** and morning sickness. H1 blockers like Promethazine or Diphenhydramine are used for these conditions but are ineffective for CINV. * **C. Dopamine D2 receptor:** While D2 receptors in the CTZ play a role in vomiting caused by opioids or metabolic disturbances (e.g., uremia), they are secondary to 5-HT3 in the context of highly emetogenic chemotherapy. D2 antagonists (e.g., Metoclopramide) are used as adjunctive therapy. * **D. Opioid μ receptor:** Activation of these receptors (by drugs like Morphine) actually *induces* nausea and vomiting by stimulating the CTZ. Opioid antagonists are not used to treat CINV. **High-Yield Clinical Pearls for NEET-PG:** * **Ondansetron** is the drug of choice for **acute** CINV (first 24 hours). * **Aprepitant** (a Substance P/NK1 receptor antagonist) is the drug of choice for **delayed** CINV (after 24 hours). * **Cisplatin** is the most highly emetogenic chemotherapy agent. * **Side effect of 5-HT3 blockers:** Headache and constipation are common; QTc prolongation is a rare but serious concern.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free